Role of Breast Cancer Resistance Protein (BCRP/ABCG2) in Cancer Drug Resistance

Por Natarajan, Karthika, Xie, Yi, Baer, Maria R., Ross, Douglas D.
Publicado em 2012

Diagnosis of biphenotypic acute leukemia: a paradigmatic approach

Por Zhao, Xianfeng Frank, Gojo, Ivana, York, Teresa, Ning, Yi, Baer, Maria R.
Publicado em 2010

Effects of Toll-like receptor signals in T-cell neoplasms

Por Morrison, Cori, Baer, Maria R, Zandberg, Dan P, Kimball, Amy, Davila, Eduardo
Publicado em 2011

“Outcome of Older Patients with Acute Myeloid Leukemia: An analysis of SEER Data over Three Decades”

Por Thein, Mya S., Ershler, William B., Jemal, Ahmedin, Yates, Jerome W., Baer, Maria R.
Publicado em 2013

Cryptic chromosome abnormalities in a patient with mixed phenotype acute leukemia

Por Ning, Yi, Slovak, Marilyn L., Schultz, Roger A., Gojo, Ivana, Baer, Maria R.
Publicado no Leuk Lymphoma (2013)

Pim-1 Kinase Phosphorylates and Stabilizes 130 kDa FLT3 and Promotes Aberrant STAT5 Signaling in Acute Myeloid Leukemia with FLT3 Internal Tandem Duplication

Por Natarajan, Karthika, Xie, Yingqiu, Burcu, Mehmet, Linn, Douglas E., Qiu, Yun, Baer, Maria R.
Publicado em 2013

Effect of Erythropoiesis-Stimulating Agent Policy Decisions on Off-Label Use in Myelodysplastic Syndromes

Por Hendrick, Franklin, Davidoff, Amy J., Zeidan, Amer M., Gore, Steven D., Baer, Maria R.
Publicado no Medicare Medicaid Res Rev (2014)

p53-inducible ribonucleotide reductase (p53R2/RRM2B) is a DNA hypomethylation-independent decitabine gene target that correlates with clinical response in MDS/AML

Por Link, Petra A., Baer, Maria R., James, Smitha R., Jones, David A., Karpf, Adam R.
Publicado em 2008

The constitutive androstane receptor is a novel therapeutic target facilitating cyclophosphamide-based treatment of hematopoietic malignancies

Por Wang, Duan, Li, Linhao, Yang, Hui, Ferguson, Stephen S., Baer, Maria R., Gartenhaus, Ronald B., Wang, Hongbing
Publicado em 2013

Drug resistance: Still a daunting challenge to the successful treatment of AML

Por Shaffer, Brian C., Gillet, Jean-Pierre, Patel, Chirayu, Baer, Maria R., Bates, Susan E., Gottesman, Michael M.
Publicado em 2012

The FLT3 Inhibitor Quizartinib Inhibits ABCG2 at Pharmacologically Relevant Concentrations, with Implications for Both Chemosensitization and Adverse Drug Interactions

Por Bhullar, Jasjeet, Natarajan, Karthika, Shukla, Suneet, Mathias, Trevor J., Sadowska, Mariola, Ambudkar, Suresh V., Baer, Maria R.
Publicado em 2013

The Pim kinase inhibitor SGI-1776 decreases cell surface expression of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and drug transport by Pim-1-dependent and...

Por Natarajan, Karthika, Bhullar, Jasjeet, Shukla, Suneet, Burcu, Mehmet, Chen, Zhe-Sheng, Ambudkar, Suresh V., Baer, Maria R.
Publicado em 2012

Erythropoiesis-stimulating agents are not associated with increased risk of thrombosis in patients with myelodysplastic syndromes

Por Smith, Sheila Weiss, Sato, Masayo, Gore, Steven D., Baer, Maria R., Ke, Xuehua, McNally, Diane, Davidoff, Amy
Publicado em 2012

Patterns of erythropoiesis-stimulating agent use among Medicare beneficiaries with myelodysplastic syndromes and consistency with clinical guidelines

Por Davidoff, Amy J., Weiss, Sheila R., Baer, Maria R., Ke, Xuehua, Hendrick, Franklin, Zeidan, Amer, Gore, Steven D.
Publicado em 2013

Inhibition of IRAK1/4 sensitizes T cell acute lymphoblastic leukemia to chemotherapies

Por Li, Zhaoyang, Younger, Kenisha, Gartenhaus, Ronald, Joseph, Ann Mary, Hu, Fang, Baer, Maria R., Brown, Patrick, Davila, Eduardo
Publicado no J Clin Invest (2015)

Targeting abnormal DNA double strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemias

Por Tobin, Lisa A., Robert, Carine, Rapoport, Aaron P., Gojo, Ivana, Baer, Maria R., Tomkinson, Alan E., Rassool, Feyruz V.
Publicado em 2012

Activation of the constitutive androstane receptor increases the therapeutic index of CHOP in lymphoma treatment

Por Hedrich, William D., Xiao, Jingwei, Heyward, Scott, Zhang, Yao, Zhang, Junran, Baer, Maria R., Hassan, Hazem E., Wang, Hongbing
Publicado no Mol Cancer Ther (2016)

Treatment and outcomes for chronic myelomonocytic leukemia compared to myelodysplastic syndromes in older adults

Por Zandberg, Dan P., Huang, Ting-Ying, Ke, Xuehua, Baer, Maria R., Gore, Steven D., Smith, Sheila Weiss, Davidoff, Amy J.
Publicado em 2013

Ponatinib enhances anticancer drug sensitivity in MRP7-overexpressing cells

Por SUN, YUE-LI, KUMAR, PRIYANK, SODANI, KAMLESH, PATEL, ATISH, PAN, YIHANG, BAER, MARIA R., CHEN, ZHE-SHENG, JIANG, WEN-QI
Publicado em 2014

c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase-activated Leukemias

Por Muvarak, Nidal, Kelley, Shannon, Robert, Carine, Baer, Maria R., Perrotti, Danilo, Gambacorti-Passerini, Carlo, Civin, Curt, Scheibner, Kara, Rassool, Feyruz
Publicado no Mol Cancer Res (2015)